Vincent van Houten, MSc
Vincent van Houten joined Forbion in 2007 and as of January 2016 is Chief Financial Officer of Forbion.
Since the start of his employment at Forbion, Vincent has played an active role in setting up and maintaining the Forbion investment funds. Vincent holds a Master’s degree in Financial Management from the University of Amsterdam and has a Finance and Accounting background. He is responsible for the overall financial and fiscal matters of the Forbion group. Vincent has experience in the trust business, especially in corporate and fiscal (re)structuring. In that respect he also assists the Investment Team on portfolio related financial topics. In addition Vincent, from 2012-2015 was partially seconded by Forbion to act as Chief Financial Officer of Dezima Pharma B.V. (a Forbion portfolio company). As such he has also played an active role in the sale of Dezima to Amgen in 2015. Currently, Vincent serves as part-time CFO of NorthSea Therapeutics.